Medical AI unicorn OpenEvidence is rumored to once again have intentions of fundraising, with a potential valuation reaching 20 billion US dollars.

On July 18th, it was reported that the medical artificial intelligence startup company OpenEvidence, known as the "Doctor Version ChatGPT", is preparing for a new round of financing. It is reported that due to its strong performance in clinical decision support and medical data analysis, external venture capital firms are offering potential valuations as high as $20 billion, actively seeking to invest in shares.